These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 24831943)

  • 21. Epstein-Barr virus in biopsies from patients with Hodgkin and non-Hodgkin lymphoma at the University of Puerto Rico immunohistochemistry laboratory.
    Córdova Pérez FJ; González-Keelan CI; Vélez R
    P R Health Sci J; 2003 Jun; 22(2):125-9. PubMed ID: 12866135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
    Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
    AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
    Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Case-control study on concentrations of organohalogen compounds and titers of antibodies to Epstein-Barr virus antigens in the etiology of non-Hodgkin lymphoma.
    Hardell E; Eriksson M; Lindström G; Van Bavel B; Linde A; Carlberg M; Liljegren G
    Leuk Lymphoma; 2001 Aug; 42(4):619-29. PubMed ID: 11697490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low- and high-grade types.
    Hummel M; Anagnostopoulos I; Korbjuhn P; Stein H
    J Pathol; 1995 Mar; 175(3):263-71. PubMed ID: 7745495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of frequency of epstein-barr virus in non- Hodgkin lymphomas Using EBV latent membrane protein 1 (EBV-LMP1) immunohistochemical staining.
    Ishtiaq S; Hassan U; Mushtaq S; Akhtar N
    Asian Pac J Cancer Prev; 2013; 14(6):3963-7. PubMed ID: 23886215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.
    Chen CJ; Lin KH; Lin SC; Tsai WC; Yen JH; Chang SJ; Lu SN; Liu HW
    J Rheumatol; 2005 Jan; 32(1):44-7. PubMed ID: 15630723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adipose tissue concentrations of dioxins and dibenzofurans, titers of antibodies to Epstein-Barr virus early antigen and the risk for non-Hodgkin lymphoma.
    Hardell L; Lindström G; van Bavel B; Hardell K; Linde A; Carlberg M; Liljegren G
    Environ Res; 2001 Oct; 87(2):99-107. PubMed ID: 11683593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistent infection by HCV and EBV in peripheral blood mononuclear cells and risk of non-Hodgkin's lymphoma.
    Richiardi L; De Marco L; Gillio-Tos A; Merletti F; Fiano V; Palli D; Masala G; Agnoli C; Tagliabue G; Panico S; Mattiello A; Tumino R; Frasca G; Vineis P; Sacerdote C
    Cancer Epidemiol; 2010 Dec; 34(6):709-12. PubMed ID: 20709616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prevalence of Epstein-Barr virus infection in head and neck non-Hodgkin's lymphomas in Khorasan, northeast of Iran.
    Abadi RZ; Sistani NS; Mohtasham N; Hesari KK; Vaezi T; Pazouki M; Shakeri MT
    J Pak Med Assoc; 2013 Jul; 63(7):882-7. PubMed ID: 23901714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non-Hodgkin lymphoma.
    Opelz G; Daniel V; Naujokat C; Döhler B
    Transplantation; 2009 Oct; 88(8):962-7. PubMed ID: 19855238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneity of risk factors and antibody profiles in epstein-barr virus genome-positive and -negative hodgkin lymphoma.
    Chang ET; Zheng T; Lennette ET; Weir EG; Borowitz M; Mann RB; Spiegelman D; Mueller NE
    J Infect Dis; 2004 Jun; 189(12):2271-81. PubMed ID: 15181575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Correlation of Epstein-Barr virus infection and childhood lymphoma].
    Xie ZD; Wang L; Lu D; Zhou CJ; Shen KL
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):365-7. PubMed ID: 18953837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of maternal Epstein-Barr virus infection and risk of acute leukemia in the offspring.
    Tedeschi R; Bloigu A; Ogmundsdottir HM; Marus A; Dillner J; dePaoli P; Gudnadottir M; Koskela P; Pukkala E; Lehtinen T; Lehtinen M
    Am J Epidemiol; 2007 Jan; 165(2):134-7. PubMed ID: 17005627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus-positive diffuse large B-cell lymphoma in children: a disease reminiscent of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.
    Uccini S; Al-Jadiry MF; Scarpino S; Ferraro D; Alsaadawi AR; Al-Darraji AF; Moleti ML; Testi AM; Al-Hadad SA; Ruco L
    Hum Pathol; 2015 May; 46(5):716-24. PubMed ID: 25704629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serologic markers of viral infection and risk of non-Hodgkin lymphoma: A pooled study of three prospective cohorts in China and Singapore.
    Bassig BA; Willhauck-Fleckenstein M; Shu XO; Koh WP; Gao YT; Purdue MP; Xiang YB; Adams-Haduch J; Wang R; Brenner N; Waterboer T; Michel A; Ji BT; Hosgood HD; Rabkin CS; Yang G; Wong JYY; Zhang J; Hu W; Seow WJ; Chow WH; Pawlita M; Zheng W; Yuan JM; Lan Q; Rothman N
    Int J Cancer; 2018 Aug; 143(3):570-579. PubMed ID: 29574937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.
    O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD
    J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human leukocyte antigens and genetic susceptibility to lymphoma.
    McAulay KA; Jarrett RF
    Tissue Antigens; 2015 Aug; 86(2):98-113. PubMed ID: 26189878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus in pediatric patients after renal transplantation.
    Schwab M; Böswald M; Korn K; Ruder H
    Clin Nephrol; 2000 Feb; 53(2):132-9. PubMed ID: 10711415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of PCR results in the diagnosis of Epstein-Barr virus infections].
    Karadağ Geçgel S; Ersoy A; Sevinir BB; Sınırtaş M; Göral G
    Mikrobiyol Bul; 2012 Oct; 46(4):594-606. PubMed ID: 23188573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.